METHOD FOR PREVENTION OF NASOPHARINGAL OF PATHOGENIC MICROFLORA CARRIAGE

FIELD: medicine. ^ SUBSTANCE: invention concerns medicine, namely to epidemiology, and concerns prophylaxes of nasopharingal carriage of a pathogenic microflora. For this purpose daily administer a Vitaflor probiotic intranasaly in a dose 2x108 CFU of lactic acid bacillus into 1 ml of dissolvent. Du...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	SUKHANOV BORIS STANISLAVOVICH, ZHOGOLEV SERGEJ DMITRIEVICH, LOBZIN JURIJ VLADIMIROVICH, DOBRITSA VALERIJ PAVLOVICH, PETROV LEONID NIKOLAEVICH, TSYGAN VASILIJ NIKOLAEVICH, ZUEVA NATAL'JA VALER'EVNA, OGARKOV PAVEL IVANOVICH, OSMOLOVSKIJ SERGEJ KONSTANTINOVICH
Format:	Patent
Sprache:	eng ; rus
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	FIELD: medicine. ^ SUBSTANCE: invention concerns medicine, namely to epidemiology, and concerns prophylaxes of nasopharingal carriage of a pathogenic microflora. For this purpose daily administer a Vitaflor probiotic intranasaly in a dose 2x108 CFU of lactic acid bacillus into 1 ml of dissolvent. Duration of administration - 3 weeks. ^ EFFECT: decrease of probability of respiratory diseases at expense of elimination of pathogenic originators and simultaneous stimulation of growth of own useful microflora. ^ 2 tbl